Transforming the Drug Eluting Stent Market in 2025: Impact Of Coronary Heart Disease On Drug-Eluting Stent Market

What Is the Expected Size and Growth Rate of the Drug Eluting Stent Market?
The market size of drug eluting stent has expanded significantly in the past few years. The market size, which was standing at $7.63 billion in 2024, is projected to increase to $8.29 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.6%. Factors like the demand for better treatment options, clinical proof, regulatory endorsement, healthcare financial aspects, guidelines, and recommendations have played a significant role in the growth observed in the historical period.

There is an anticipation for robust expansion of the drug eluting stent market in the upcoming years. It is projected to escalate to a value of $11.37 billion by 2029, with a compound annual growth rate (CAGR) of 8.2%. Several reasons like an increasing older population and rising chronic illnesses, widening of indications, healthcare compensation policies, augmentation of the worldwide market, and patient-focused healthcare are recognized as growth drivers during this forecast period. The period would also see key trends like individualized medicine, less invasive procedures, emerging health technologies and the development of next-gen drug formulations.

What Factors Are Propelling the Expansion of the Drug Eluting Stent Market?
The escalating prevalence of coronary heart disease is anticipated to drive the expansion of the drug-eluting stent market. Coronary heart disease (CHD) involves the narrowing or blockage of the coronary arteries due to plaque accumulation, which may result in serious conditions such as a heart attack or angina. Factors contributing to increasing CHD comprise inactive lifestyles, poor eating habits, aging populations, and increased knowledge of the disease. Drug-eluting stents (DES) offer a significant advantage in treating CHD by proficiently unblocking or expanding the constricted coronary arteries and delivering medication that aids in avoiding the artery from closing again (restenosis). For example, data from the Centers for Disease Control and Prevention, a US-based government agency, revealed that the percentage of adults aged 18 and over diagnosed with coronary heart disease increased from 4.6% in 2020 to 4.9% in 2022. This growth in CHD incidence is anticipated to significantly influence the growth of the drug-eluting stent market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp

Which Leading Companies Are Shaping the Growth of the Drug Eluting Stent Market?
Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.

What Are the Major Trends Shaping the Drug Eluting Stent Market?
Firms involved in the drug-eluting stent market are concentrating on the creation of innovative delivery methods such as the dual-layer balloon, with the goal of enhancing patient results and pushing forward in the field of interventional cardiology. With its enhanced control and even distribution of medicine to the arterial wall, a dual-layer balloon in a drug-eluting stent system boosts precision in medication delivery and stent deployment. For example, Medtronic Plc, a global medical supplies firm based in Ireland, introduced Onyx Frontier, their most modern drug-eluting coronary stent system, in August 2022. The new system adds advancements to the delivery systems, building on the acute performance and clinical data of the Resolute Onyx DES's earlier model. The Onyx Frontier DES system, which uses the same high-quality stent platform as the Resolute Onyx, accommodates a wide range of sizes to aid in patient treatment, from 2.0mm to 5.0mm in diameter. The Onyx Frontier DES design incorporates significant enhancements such as an innovative dual-layer balloon, decreased crossing profile, and increased catheter flexibility, resulting in a 16% improvement in deliverability compared to the previous Resolute Onyx DES model, while maintaining radial strength.

What Are the Key Segments of the Drug Eluting Stent Market?
The drug eluting stent market covered in this report is segmented -

1) By Product: Polymer-Based, Polymer-Free
2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs
3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds
4) By Application: Coronary Diseases, Peripheral Vascular Diseases
5) By End-User: Hospitals, Specialty Clinic

Subsegments:
1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents
2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

Which Region Dominates the Drug Eluting Stent Market?
North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Drug Eluting Stent Global Market Report?

- Market Size Analysis: Analyze the Drug Eluting Stent Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Drug Eluting Stent Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Drug Eluting Stent Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Drug Eluting Stent Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15557

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.